Login
Companies $VBIO
$0.55 +$0.02 (4.18%) After hours
Valion Bio, Inc. logo

Valion Bio, Inc.

tivichealth.com

What Do They Do?

Develops biologic drug candidates for government use in radiation emergencies and oncology-related conditions, and provides biomanufacturing development and manufacturing services to external customers.

How Do They Make Money?

The company sells products directly and through resellers, receiving payment when products ship.

FY2024 revenue

Who Are Their Customers?

Product buyers purchase directly or through resellers; Velocity provides contract development and manufacturing services to Tivic and external customers.

Do Revenues Turn Into Profits?

No. It lost $5.7M in FY2024.

Operating income, FY2024
−574% of revenue
▲ +46% (Loss) vs FY2023 (−$8.2M, −701%)
Net income, FY2024
−725% of revenue
▲ +31% (Loss) vs FY2023 (−$8.2M, −701%)
Free cash flow, FY2024
−734% of revenue
▲ +34% (Loss) vs FY2023 (−$8.6M, −734%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q2 FY2026, the three months to Jun 30, 2026
Net income
▼ −268% (Loss)
vs −$1.9M in Q2 FY2025
  • Oct 31, 2026 Chief financial officer plans to resign Her resignation from all three roles is set to take effect on December 11, 2026.

From consumer devices to biologics The earlier report centered on a non-invasive bioelectronic platform and ClearUP for sinus symptoms; the latest centers on Entolimod and related biologics, with consumer healthtech exited and prescription device development stopped.

Added contract manufacturing The latest report adds Velocity Bioworks, a subsidiary offering development and manufacturing services to Tivic and outside customers, alongside the company's drug-development work.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support